Testimonials

“CureMatch opens up many more treatment options beyond the standard of care – and this is so important when those treatments are failing the patient.”
Kimary Kulig, PhD, MPH

“CureMatch has been an important part of the decision-making for cancer care, especially for the patients with complexed molecular profiling results.”
Shumei Kato, MD
“The CureMatch Report has been very helpful. I have used it with my patients and it has changed my therapy decisions.”
John Link, MD
“A CureMatch Report is the dream of any oncologist. It addresses one of the pushbacks whenever we send an NGS report to an oncologist.”
Lior Soussangutman, Ph.D.

“The CureMatch report provided me with clarity about therapeutic options for my patients with metastatic cancer given that there are no clinical trials currently available at ours or other regional centers that they would be eligible for.”
Himabindu Gaddipati, MD

“The future of cancer care will rely upon personalization and precision. But, with a CureMatch Report, the future is now.”
Jason Sicklick, MD, FACS
“The CureMatch Report offers a superior genomic matching product including customized combination therapy options for informing treatment choices. The numerical score values are a powerful way to help one choose amongst possible clinical interventions.”
Rick Lanman, MD

“CureMatch is doing what makes sense in getting the right drugs to the right patients. Their therapy options with scores and targeting rationale allows oncologists to make quicker personalized treatment choices”
Jacob Adashek, DO

“CureMatch is where molecular science meets Al to revolutionize cancer care. A CureMatch Report can provide objective cutting-edge information to drive and potentially alter treatment decisions in the space of precision oncology!”
Nader Javadi, MD